Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
Basic
4
Ṁ1052026
38%
chance
1D
1W
1M
ALL
This category of drug is finding more and more uses for a variety of conditions, but the history of drugs, and weight loss drugs in particular, is legally fraught (Phen-Fen, etc.) Are we irrationally exuberant about GLP1 or is it different this time?
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
84% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
30% chance
Will Lantern Biotech get sued for over $1M by 2029?
36% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024
36% chance
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?
12% chance
What will happen to the GLP-1 / Ozempic compounding pharmacy loophole?
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance